LGND

Ligand Pharmaceuticals Incorporated

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$199.59

Market Cap

$3.98B

Beta

1.03

P/E

35.6

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+60.40%

EPS Growth (YoY)+500.00%

Revenue CAGR 3Y+15.74%

P/E Ratio35.6

PEG Ratio0.07

FCF Yield+1.23%

Debt / Equity0.44

Interest Coverage23.4x

No credit card required

Already have an account? Sign in to view the full analysis for LGND.